Australia’s active vaccine safety system

Publications

Filter

Publications

Reynolds R, Tay E, Dymock M, Deng L, Glover C, Lopez LK, Huang YA, Cashman P, Leeb A, Marsh JA, Snelling T, Wood N, Macartney K. Short-term active safety surveillance of the Spikevax and Nuvaxovid priming doses in Australia. Vaccines 2024; 12:971. doi: 10.3390/vaccines12090971 (Epub). [Full text]

O'Moore M, Jones B, Hickie M, Glover C, Deng L, Huang Y, Dymock M, Tay E, Marsh JA, Wood N. National pharmacovigilance of seasonal influenza vaccines in Australia. Medical Journal of Australia 2024. doi: 10.5694/mja2.52381 (Epub). [Full text]

Tay E, Dymock M, Lopez L, Glover C, Huang YA, Bakar KS, Snelling T, Marsh JA, Wu Y. Applying causal inference and bayesian statistics to understanding vaccine safety signals using a simulation study. NPJ Vaccines 2024;9:163. doi: 10.1038/s41541-024-00955-4. [Full text]

Muttucumaru R, Lau CL, Leeb A, Mills DJ, Wood N, Furuya-Kanamori L. Post-marketing surveillance of 10,392 herpes zoster vaccines doses in Australia. Vaccine 2024;42:3166-3171. doi: 10.1016/j.vaccine.2024.03.066. [Full text]

Imai C, Jayasinghe S, McRae J, Li-Kim-Moy J, Chiu C, Macartney K, Burns P, Cooper K, Cheng AC, Gibney K, Giles M, Jones C, Korman T, Liu B, Crawford NW; Australian Technical Advisory Group on Immunisation (ATAGI). . Surveillance of adverse events following immunisation in Australia annual report, 2021. Communicable Diseases Intelligence (2018) 2024;48. doi: 10.33321/cdi.2024.48.25. [Full text]

Tran H, Deng L, Wood N, Choi P, Singleton S, Clarke L, Khanlari S, Maitland-Scott I, Bird R, Brown S, Manoharan B, Tan C, Gold M, Hissaria P, Melody S, Chunilal S, Buttery J, Clothier H, Crawford N, Phuong L, Pepperell D, Effler P, Parker C, Carter N. The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study. The Lancet Western Pacific 2023;40:100894. doi:10.1016/j.lanwpc.2023.100894. [Full text]

Deng L, Lopez L, Glover C, Cashman P, Reynolds R, Macartney K, Wood N. Short-term adverse events following immunization with Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine for Mpox. JAMA 2023;329:2091-2094. doi:10.1001/jama.2023.7683. [Full text]

Deng L, Glover C, Dymock M, Pillsbury A, Marsh JA, Quinn HE, Leeb A, Cashman P, Snelling TL, Wood N, Macartney K. The short term safety of COVID‐19 vaccines in Australia: AusVaxSafety active surveillance, February – August 2021. Medical Journal of Australia 2022;217:195-202. doi: 10.5694/mja2.51619. [Full text]

Hamilton E, Oversby S, Kitchener S, Ratsch A. Post COVID-19 vaccination: AusVaxSafety survey participation and adverse events - a community-based regional Queensland study. Australian and New Zealand Journal of Public Health 2022;46:738-744. doi: 10.1111/1753-6405.13300 . [Full text]

Salter SM, Li D, Trentino K, Nissen L, Lee K, Orlemann K, Peters I, Murray K, Leeb A, Deng L. Safety of four COVID-19 vaccines across primary doses 1, 2, 3 and booster: a prospective cohort study of Australian community pharmacy vaccinations. Vaccines (Basel) 2022;10:2017. doi: 10.3390/vaccines10122017. [Full text]

AusVaxSafety receives funding
from the Australian Government

NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433  |  Fax (612) 9845 1418  |  ABN 53 188 579 090

We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.

Copyright © 2024 AusVaxSafety. All rights reserved

vaccine

Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.

NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433  |  Fax (612) 9845 1418  |  ABN 53 188 579 090

Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.

We acknowledge that the National Centre for Immunisation Research & Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.